Remove 2028 Remove Documentation Remove Hospitals
article thumbnail

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

pharmaphorum

According to Novartis, Kesimpta is the first targeted B cell therapy for RMS that can be self-administered at home once a month using an autoinjector, avoiding the need for patients to travel to hospital during the pandemic, and easing the pressure on clinicians. billion by 2028. billion in sales in 2028.

Hospitals 111
article thumbnail

A history of blood cancer treatment

pharmaphorum

During his time working in the pathology museum at Guy’s Hospital in London, Hodgkin studied several preserved specimens of human organs affected by disease. The first well-documented case of multiple myeloma was reported in 1844 by renowned British surgeon Samuel Solly. 1844 – First reported case of multiple myeloma.

article thumbnail

NHC Submits Comments to CMS on Advance Notice of Methodological Changes for CY 2026 for Medicare Advantage Capitation Rates and Part C and Part D Payment Policies

Putting Patients First Blog

CMS should also work directly with providers to minimize administrative burdens caused by risk adjustment changes, as increased documentation requirements could further strain providers, particularly those treating high-cost populations. Equally critical is clear and accessible communication with beneficiaries. 3 American Medical Association.